Cardiac tissue engineering: Multiple approaches and potential applications.
biomaterial
cardiac tissue
hiPSC
organoids
scaffold
Journal
Frontiers in bioengineering and biotechnology
ISSN: 2296-4185
Titre abrégé: Front Bioeng Biotechnol
Pays: Switzerland
ID NLM: 101632513
Informations de publication
Date de publication:
2022
2022
Historique:
received:
28
06
2022
accepted:
26
08
2022
entrez:
20
10
2022
pubmed:
21
10
2022
medline:
21
10
2022
Statut:
epublish
Résumé
The overall increase in cardiovascular diseases and, specifically, the ever-rising exposure to cardiotoxic compounds has greatly increased
Identifiants
pubmed: 36263357
doi: 10.3389/fbioe.2022.980393
pii: 980393
pmc: PMC9574555
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
980393Informations de copyright
Copyright © 2022 Gisone, Cecchettini, Ceccherini, Persiani, Morales and Vozzi.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Cell Tissue Res. 2021 May;384(2):231-240
pubmed: 33544212
Methods Mol Biol. 2021;2193:129-140
pubmed: 32808265
Arch Toxicol. 2018 Jan;92(1):371-381
pubmed: 28940058
Tissue Eng Part C Methods. 2020 Jan;26(1):44-55
pubmed: 31797733
Sci Rep. 2020 Mar 26;10(1):5484
pubmed: 32218447
Sci Rep. 2021 Mar 11;11(1):5654
pubmed: 33707655
Biomaterials. 2020 Jan;227:119551
pubmed: 31670034
Exp Mech. 2019 Nov;59(9):1235-1248
pubmed: 31680699
Biochim Biophys Acta. 2015 Feb;1853(2):276-84
pubmed: 25450968
Methods Mol Biol. 2019;2002:51-59
pubmed: 30159827
Development. 2017 Mar 15;144(6):1008-1017
pubmed: 28279973
Life Sci. 2021 Dec 1;286:120028
pubmed: 34627776
Environ Pollut. 2021 Jan 1;268(Pt B):115861
pubmed: 33120150
Anal Bioanal Chem. 2018 Sep;410(24):6141-6154
pubmed: 29744562
J Mol Cell Cardiol. 2022 Apr;165:19-30
pubmed: 34959166
Nat Protoc. 2021 Apr;16(4):2213-2256
pubmed: 33772245
Int J Biochem Cell Biol. 2005 Sep;37(9):1746-51
pubmed: 15950518
Bioact Mater. 2021 Jun 10;7:275-291
pubmed: 34466733
Arch Med Sci. 2018 Jun;14(4):910-919
pubmed: 30002710
J Mol Cell Cardiol. 2021 Aug;157:56-65
pubmed: 33895197
Front Physiol. 2012 Sep 05;3:345
pubmed: 22973235
Stem Cell Reports. 2017 Nov 14;9(5):1406-1414
pubmed: 28988990
World J Cardiol. 2019 Oct 26;11(10):221-235
pubmed: 31754410
Circ Res. 2020 Apr 10;126(8):1086-1106
pubmed: 32271675
Toxicol In Vitro. 2020 Sep;67:104891
pubmed: 32446838
Front Cardiovasc Med. 2018 Jul 26;5:101
pubmed: 30175102
Acta Biomater. 2020 Jan 15;102:273-286
pubmed: 31778832
Adv Biol (Weinh). 2022 Jan;6(1):e2000526
pubmed: 34837667
Sci Rep. 2021 May 13;11(1):10228
pubmed: 33986332
Sci Rep. 2020 Aug 11;10(1):13575
pubmed: 32782331
Cell Stem Cell. 2020 Jun 4;26(6):862-879.e11
pubmed: 32459996
Biochim Biophys Acta. 2016 Jul;1863(7 Pt B):1728-48
pubmed: 26524115
Mol Biol Cell. 2016 Jul 15;27(14):2149-60
pubmed: 27418636
Pflugers Arch. 2021 Jul;473(7):1061-1085
pubmed: 33629131
Future Sci OA. 2015 Nov 01;1(4):FSO63
pubmed: 28031915
Int J Mol Sci. 2020 May 11;21(9):
pubmed: 32403456
J Vis Exp. 2018 Aug 5;(138):
pubmed: 30124650
Nat Nanotechnol. 2010 Apr;5(4):291-6
pubmed: 20228788
Front Cell Dev Biol. 2021 Apr 16;9:670504
pubmed: 33937272
Expert Opin Drug Metab Toxicol. 2021 Aug;17(8):887-902
pubmed: 33612039
Chem Res Toxicol. 2021 Feb 15;34(2):566-583
pubmed: 33346635
Front Mol Biosci. 2020 Feb 14;7:14
pubmed: 32118040
Stem Cells Dev. 2013 Jul 15;22(14):1991-2002
pubmed: 23461462